Guangkun Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guangkun Nie has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Shenda Hong
National Institute of Health Data Science, Peking University, Beijing, China
5 shared publications - Bo Liu
State Key Laboratory of General Artificial Intelligence, School of Intelligence Science and Technology, Peking University, Beijing, China
3 shared publications - Hongyan Li
State Key Laboratory of General Artificial Intelligence Peking University
3 shared publications - Xiaocheng Fang
State Key Laboratory of General Artificial Intelligence, School of Intelligence Science and Technology, Peking University, Beijing, China
3 shared publications Gongzheng Tang
National Institute of Health Data Science, Peking University, Beijing, China
2 shared publications- Jiarui Jin
State Key Laboratory of General Artificial Intelligence, School of Intelligence Science and Technology, Peking University, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 10877-10888
ECGFlowCMR: Pretraining with ECG-Generated Cine CMR Helps Cardiac Disease Classification and Phenotype Prediction
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 10877-10888
Open AccessECGFlowCMR: Pretraining with ECG-Generated Cine CMR Helps Cardiac Disease Classification and Phenotype Prediction
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11717-11727
AnyPPG: An ECG-Guided PPG Foundation Model Trained on Over 100,000 Hours of Recordings for Holistic Health Profiling
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11717-11727
Open AccessAnyPPG: An ECG-Guided PPG Foundation Model Trained on Over 100,000 Hours of Recordings for Holistic Health Profiling
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11422-11431
CausalMoE: A Billion-Scale Multimodal Foundation Model for Granger Causal Discovery with Pattern-Routed Heterogeneous Experts
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11422-11431
Open AccessCausalMoE: A Billion-Scale Multimodal Foundation Model for Granger Causal Discovery with Pattern-Routed Heterogeneous Experts
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Health Data Science
- Vol. 6
A Scoping Review of Deep Learning Methods for Photoplethysmography Data
Background: Photoplethysmography (PPG) is a noninvasive optical sensing technique widely used to capture hemodynamic information, with broad deployment in both clinical monitoring systems and wearable devices. In recent years, the integration of deep learning has substantially advanced PPG signal analysis and expanded its applications across healthcare and nonhealthcare domains. Methods: We conducted a comprehensive literature search for studies applying deep learning to PPG data published between 2017 January 1 and 2025 December 31, using Google Scholar, PubMed, and Dimensions. The included studies were analyzed from 3 key perspectives: tasks, models, and data. Results: A total of 460 papers applying deep learning techniques to PPG signal analysis were included. These studies span a wide range of application domains, from traditional physiological monitoring tasks such as cardiovascular assessment to emerging applications including sleep analysis, cross-modality signal reconstruction, and biometric identification. Conclusions: Deep learning has substantially advanced PPG signal analysis by enabling more effective extraction of physiological information. Compared with traditional machine learning approaches reliant on handcrafted features, deep learning methods generally achieve improved performance and offer greater flexibility in model development. Nevertheless, several challenges remain, including limited availability of large-scale high-quality datasets, insufficient validation in real-world environments, and concerns over model interpretability, scalability, and computational efficiency. Addressing these challenges and exploring emerging research directions will be essential for further progress in deep learning-based PPG analysis.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Health Data Science
- Vol. 6
A Scoping Review of Deep Learning Methods for Photoplethysmography Data
Background: Photoplethysmography (PPG) is a noninvasive optical sensing technique widely used to capture hemodynamic information, with broad deployment in both clinical monitoring systems and wearable devices. In recent years, the integration of deep learning has substantially advanced PPG signal analysis and expanded its applications across healthcare and nonhealthcare domains. Methods: We conducted a comprehensive literature search for studies applying deep learning to PPG data published between 2017 January 1 and 2025 December 31, using Google Scholar, PubMed, and Dimensions. The included studies were analyzed from 3 key perspectives: tasks, models, and data. Results: A total of 460 papers applying deep learning techniques to PPG signal analysis were included. These studies span a wide range of application domains, from traditional physiological monitoring tasks such as cardiovascular assessment to emerging applications including sleep analysis, cross-modality signal reconstruction, and biometric identification. Conclusions: Deep learning has substantially advanced PPG signal analysis by enabling more effective extraction of physiological information. Compared with traditional machine learning approaches reliant on handcrafted features, deep learning methods generally achieve improved performance and offer greater flexibility in model development. Nevertheless, several challenges remain, including limited availability of large-scale high-quality datasets, insufficient validation in real-world environments, and concerns over model interpretability, scalability, and computational efficiency. Addressing these challenges and exploring emerging research directions will be essential for further progress in deep learning-based PPG analysis.
- Open Access
- 19 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 481
Artificial intelligence-derived photoplethysmography age as a digital biomarker for cardiovascular health
Photoplethysmography (PPG), increasingly available through wearable devices, provides a non-invasive means of monitoring human hemodynamics. In this study, we introduce artificial intelligence-derived photoplethysmography (AI-PPG) age, a deep learning-based estimate of biological age from raw PPG signals, and evaluate its potential as a digital biomarker for cardiovascular health. We developed a deep learning model with a distribution-aware loss function to reduce bias from imbalanced data. The model was trained and evaluated on the UK Biobank cohort (N = 212,231). We analyzed the association between the AI-PPG age gap (AI-PPG age minus calendar age) and multiple cardiovascular and metabolic outcomes, assessed its longitudinal value using serial PPG measurements, and externally validated its generalizability in an independent MIMIC-III-derived cohort (N = 2343). After adjusting for key confounders, participants with an AI-PPG age gap greater than 9 years have a significantly higher risk of major adverse cardiovascular and cerebrovascular events (hazard ratio of 2.37, p = 8.46 × 10-80), as well as seven secondary outcomes including coronary heart disease and myocardial infarction (all p < 0.005). Conversely, those with a gap below -9 years show a lower risk profile. Longitudinal analysis demonstrates that changes in AI-PPG age add predictive value over time. In the external validation cohort, each one-year increase in AI-PPG age gap is associated with higher in-hospital mortality (odds ratio of 1.02, p = 0.01). AI-PPG age is a scalable, non-invasive biomarker for cardiovascular health assessment. Integrated with wearable devices, it may enable population-level screening, personalized monitoring, and early intervention.
- 19 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 481
Open AccessArtificial intelligence-derived photoplethysmography age as a digital biomarker for cardiovascular health
Photoplethysmography (PPG), increasingly available through wearable devices, provides a non-invasive means of monitoring human hemodynamics. In this study, we introduce artificial intelligence-derived photoplethysmography (AI-PPG) age, a deep learning-based estimate of biological age from raw PPG signals, and evaluate its potential as a digital biomarker for cardiovascular health. We developed a deep learning model with a distribution-aware loss function to reduce bias from imbalanced data. The model was trained and evaluated on the UK Biobank cohort (N = 212,231). We analyzed the association between the AI-PPG age gap (AI-PPG age minus calendar age) and multiple cardiovascular and metabolic outcomes, assessed its longitudinal value using serial PPG measurements, and externally validated its generalizability in an independent MIMIC-III-derived cohort (N = 2343). After adjusting for key confounders, participants with an AI-PPG age gap greater than 9 years have a significantly higher risk of major adverse cardiovascular and cerebrovascular events (hazard ratio of 2.37, p = 8.46 × 10-80), as well as seven secondary outcomes including coronary heart disease and myocardial infarction (all p < 0.005). Conversely, those with a gap below -9 years show a lower risk profile. Longitudinal analysis demonstrates that changes in AI-PPG age add predictive value over time. In the external validation cohort, each one-year increase in AI-PPG age gap is associated with higher in-hospital mortality (odds ratio of 1.02, p = 0.01). AI-PPG age is a scalable, non-invasive biomarker for cardiovascular health assessment. Integrated with wearable devices, it may enable population-level screening, personalized monitoring, and early intervention.